Chewy Inc
4 nominees · 3 ballot items.
Chewy's 2025 Annual Meeting includes Proposal 1: Election of four directors for three-year terms; Proposal 2: Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending February 1, 2026; and Proposal 3: Advisory vote on named executive officer compensation.
Follow how the vote landed and what changed on Chewy Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of four director nominees for three-year terms on Chewy's Board.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatification of the appointment of Deloitte & Touche LLP as Chewy's independent registered public accounting firm for the fiscal year ending February 1, 2026.
- 3
Advisory Vote on Named Executive Officer Compensation
ManagementBoard: FORAdvisory, non-binding vote to approve the compensation of Chewy's named executive officers.
Nominees on the ballot4
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BC Partners PE LP | 43.1% | 176,478,228 | $4.8B |
| 2 | AQR CAPITAL MANAGEMENT LLC | 3.9% | 16,071,607 | $431M |
| 3 | BlackRock, Inc. | 3.4% | 13,864,477 | $374M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5% | 10,381,453 | $280M |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5% | 10,045,653 | $271M |
| 6 | STATE STREET CORP | 1.8% | 7,174,273 | $194M |
| 7 | BlackRock, Inc. | 1.6% | 6,350,998 | $171M |
| 8 | TWO SIGMA INVESTMENTS, LP | 1.5% | 6,212,892 | $168M |
| 9 | Point72 Asset Management, L.P.Activist | 1.3% | 5,272,958 | $142M |
| 10 | CANADA PENSION PLAN INVESTMENT BOARD | 1.3% | 5,231,293 | $141M |
Other Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Chewy Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Chewy Inc 2025 annual meeting?
- Chewy Inc (CHWY) holds its 2025 annual shareholder meeting on Thursday, July 10, 2025.
- What is the record date for the Chewy Inc 2025 meeting?
- The record date for the Chewy Inc 2025 meeting is Monday, May 12, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Chewy Inc's 2025 meeting?
- The board is presenting 4 director nominees at the Chewy Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Chewy Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Chewy Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.